FTXH - First Trust Nasdaq Pharmaceuticals ETF (USD) (US33738R8372)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Hepsini seç Hepsini sıfırla

Kaydet Kapat

(%)

US33738R8372

FTXH ISIN

Borsa Yatırım Fonları (BYF)

Fon türü

First Trust

Sağlayıcı

39,59 USD

Hisse başına net varlık değeri | 07.08.2026

20.09.2016

Başlangıç tarihi

4 yılda ... kez

Temettü ödemeleri

CEOXMX

CFI

FTXH

Menkul değer sembolü

Formed

Status

Equity

Yatırım kategorisi

Healthcare

Sektör

USA

Coğrafya

Nasdaq US Smart Pharmaceuticals Index

Karşılaştırma ölçütü (benchmark)

0.6 %

Toplam Maliyet Oranı

37,89 milyon USD

Fonun toplam varlıkları | 15.07.2026

Hayır

UCITS

Getiri on 07.08.2026, NASDAQ

YTD

1,9 %
1M

-3,36 %
3M

-4,14 %
6M

6,24 %
1Y

35,3 %
3Y

33,95 %
5Y

36,59 %
10Y

-

Gelir ödemeleri dikkate alınarak borsadaki fiyat üzerinden

Şu tarihe ilişkin son veriler

Karşılaştırmak için öğe ekleyin

Kotasyonlar (FTXH)

En kapsamlı veri tabanını keşfedin

1 000 000

tahvi̇ller

100 000

hisse senetleri

175 910

ETF & Funds

100 000

endeksler

Portföyünüzü en etkili şekilde takip edin

Tahvi̇l arama
Watchlist
Excel Eklentisi

Erişim sağlamak

Fiyat dinamiklerindeki değişimler

FTXH profile

The First Trust Nasdaq Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 20.09.2016 with unique ISIN - US33738R8372. Main exchange is NASDAQ and ticker symbol is FTXH. The total expense ratio is 0.6%. The First Trust Nasdaq Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Yapı FTXH on 07.08.2026

Excel'de yapıyı indir

Menkul kıymet	Değer
Eli Lilly and Company	7,43%
AbbVie Inc.	7,01%
Johnson & Johnson	6,9%
Merck & Co., Inc.	6,87%
Bristol-Myers Squibb Company	6,86%
Viatris Inc.	3,64%
Biogen Inc.	3,58%
Amgen Inc.	3,51%
Cardinal Health, Inc.	3,42%
Regeneron Pharmaceuticals, Inc.	3,33%
Vertex Pharmaceuticals Incorporated	3,31%
Pfizer Inc.	3,2%
Gilead Sciences, Inc.	2,95%
United Therapeutics Corporation	2,64%
Jazz Pharmaceuticals Plc	2,57%
Incyte Corporation	2,47%
Illumina, Inc.	2,06%
Zoetis Inc.	1,83%
Charles River Laboratories International, Inc.	1,7%
Exelixis, Inc.	1,66%
Halozyme Therapeutics, Inc.	1,55%
Medpace Holdings, Inc.	1,52%
Neurocrine Biosciences, Inc.	1,29%
Alkermes Plc	1,23%
BioMarin Pharmaceutical Inc.	1,21%
PTC Therapeutics, Inc.	1,2%
Twist Bioscience Corporation	1,12%
Spyre Therapeutics, Inc.	1,11%
10X Genomics, Inc. (Class A)	1,03%
Travere Therapeutics, Inc.	0,94%
Guardant Health, Inc.	0,82%
TG Therapeutics, Inc.	0,75%
Elanco Animal Health Incorporated	0,72%
Protagonist Therapeutics, Inc.	0,72%
Amneal Pharmaceuticals, Inc.	0,7%
Arrowhead Pharmaceuticals, Inc.	0,69%
Ligand Pharmaceuticals Inc. (Class B)	0,67%
Arcus Biosciences, Inc.	0,64%
Roivant Sciences Ltd.	0,57%
ACADIA Pharmaceuticals Inc.	0,54%
Krystal Biotech, Inc.	0,54%
Kymera Therapeutics, Inc.	0,54%
Mirum Pharmaceuticals, Inc.	0,5%
Moderna, Inc.	0,5%
Arcutis Biotherapeutics, Inc.	0,43%
Supernus Pharmaceuticals, Inc.	0,39%
Tarsus Pharmaceuticals, Inc.	0,39%
Ionis Pharmaceuticals, Inc.	0,32%
Alnylam Pharmaceuticals, Inc.	0,3%
US Dollar	0,15%

Tümünü göster Gizle

Other - %

Bu sağlayıcıdan diğer ETF ve Fonlar

Benzer ETF ve Fonlar

{{ item.etf.ttl }}

{{ item.nav_usd }} milyon
Net Varlık Değeri

{{ item.expense_ratio }}
Toplam Maliyet Oranı